- Bioresorbable scaffold implantation in STEMI patients: 5 years imaging subanalysis of PRAGUE-19 study2020 | 1. lékařská fakulta, 3. lékařská fakulta
- Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial2019 | 3. lékařská fakulta
- Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial2018 | 3. lékařská fakulta
- Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study2020 | 3. lékařská fakulta
- Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study2016 | 1. lékařská fakulta, 3. lékařská fakulta
- Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE- ABSORB randomised clinical trial2020 | 3. lékařská fakulta
- One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction The PRAGUE-19 Study2015 | 3. lékařská fakulta
- Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial2021 | 1. lékařská fakulta, 3. lékařská fakulta, Ústřední knihovna
- Protidestičková léčba po implantaci vstřebatelných stentů2017 | 1. lékařská fakulta
- Koronární stenty2017 | Lékařská fakulta v Hradci Králové